The evolution of pathogens to resist the drugs used to treat infections is an ongoing threat to public health, animal health, food production, and national security. Globally, a recent analysis estimated that 1.2 million deaths were caused by antibiotic-resistant (AR) bacteria in 2019, making this threat a leading cause of death for people of all ages worldwide.
Biomedical Research, Science, & Technology
Discover research in the areas of Biomedical Innovation, Electronic Health Records, Information Technology, and Medical Product Development.
Noteworthy
Reports
Displaying 31 - 40 of 272. 10 per page. Page 4.
Advanced SearchReport
National Action Plan for Combating Antibiotic-Resistant Bacteria Progress Report: Fiscal Year 2022
ASPE Issue Brief
Barriers and Opportunities for Improving Interstate Licensure Portability for Behavioral Health Practitioners: Technical Expert Panel Findings Issue Brief
In October 2022, ASPE convened a virtual technical expert panel (TEP) to discuss policy options that encourage interstate licensure among behavioral health providers.
ASPE Issue Brief, Report
Evaluation of the Assisted Outpatient Treatment Grant Program for Individuals with Serious Mental Illness
Environmental Scan
Impact of COVID-19 on Clinical Trials Costs to Patients
This environmental scan, conducted by Mathematica and funded by ASPE, examines the types of direct and direct costs to patients associated with clinical trial participation. It also explores the effect of COVID-19 on costs to patients, including cost implications of clinical trial innovations widely implemented during COVID-19 and other efforts to increase diversity of clinical trials.
ASPE Issue Brief, Report
Transformation of the Clinical Trial Enterprise: Lessons Learned from the COVID-19 Pandemic
In 2023, ASPE launched a research project to understand the impacts of COVID-19 on the clinical trial enterprise and identify key lessons learned.
ASPE Issue Brief
Medical Product Shortages in the United States: Demographic and Geographic Factors and Impacts
Medical product shortages are an ongoing public health concern, with at least 140 products in shortage as of July 2024.We use the Household Pulse Survey to examine how many adults are affected by shortages of critical medical products in the United States.In fall 2023, shortages of medical products impacted about 38.8 million (18 percent) of individuals in the United Stat
Report
The Potential Role of The Nonprofit Pharmaceutical Industry in Addressing Shortages and Increasing Access to Essential Medicines and Low-Cost Medicines
We report findings of a study that described the emerging nonprofit pharmaceutical industry and its commercialization activities to enhance access to affordable and essential drugs, or resiliency in the supply chains of medical products.
ASPE Data Point
Nurse Staffing Estimates in US Nursing Homes, May 2024
In April 2024, CMS issued the Minimum Staffing Standards for Long-Term Care Facilities and Medicaid Institutional Payment Transparency Reporting final rule which established new minimum nurse staffing requirements for nursing homes by nurse type.
Research Summary
Costs of Drug Development and Research and Development Intensity in the US, 2000-2018
This landing page represents the abstract of a paper published in JAMA. The full text of the article is available at: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2820562.Abstract
ASPE Issue Brief
Improving Data on the Workforce Delivering Home and Community-Based Services
On April 25, 2024, HHS and DoL released recommendations, in the form of an Issue Brief, to improve data infrastructure on the workforce delivering home and community-based services (HCBS) in response to President Biden’s